A citation-based method for searching scientific literature

Massimo Santoro, Francesca Carlomagno. Cold Spring Harb Perspect Biol 2013
Times Cited: 69



Doron Lipson, Marzia Capelletti, Roman Yelensky, Geoff Otto, Alex Parker, Mirna Jarosz, John A Curran, Sohail Balasubramanian, Troy Bloom, Kristina W Brennan, Amy Donahue, Sean R Downing, Garrett M Frampton, Lazaro Garcia, Frank Juhn, Kathy C Mitchell, Emily White, Jared White, Zac Zwirko, Tamar Peretz, Hovav Nechushtan, Lior Soussan-Gutman, Jhingook Kim, Hidefumi Sasaki, Hyeong Ryul Kim, Seung-il Park, Dalia Ercan, Christine E Sheehan, Jeffrey S Ross, Maureen T Cronin, Pasi A Jänne, Philip J Stephens. Nat Med 2012
Times Cited: 622




List of shared articles



Times cited

Progresses Toward Precision Medicine in RET-altered Solid Tumors.
Carmen Belli, Santosh Anand, Justin F Gainor, Frederique Penault-Llorca, Vivek Subbiah, Alexander Drilon, Fabrice Andrè, Giuseppe Curigliano. Clin Cancer Res 2020
15

Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases.
Marialuisa Moccia, Donglin Yang, Naga Rajiv Lakkaniga, Brendan Frett, Nicholas McConnell, Lingtian Zhang, Annalisa Brescia, Giorgia Federico, Lingzhi Zhang, Paolo Salerno,[...]. Sci Rep 2021
0

OLFM4-RET fusion is an oncogenic driver in small intestine adenocarcinoma.
Wenli Liu, Hongzhen Li, Wulin Aerbajinai, Istvan Botos, Griffin P Rodgers. Oncogene 2022
3

ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research.
C Belli, F Penault-Llorca, M Ladanyi, N Normanno, J-Y Scoazec, L Lacroix, J S Reis-Filho, V Subbiah, J F Gainor, V Endris,[...]. Ann Oncol 2021
32

Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.
Alexander Drilon, Zishuo I Hu, Gillianne G Y Lai, Daniel S W Tan. Nat Rev Clin Oncol 2018
141

Thyroid C-Cell Biology and Oncogenic Transformation.
Gilbert J Cote, Elizabeth G Grubbs, Marie-Claude Hofmann. Recent Results Cancer Res 2015
28

Analytical Accuracy of RET Fusion Detection by Break-Apart Fluorescence In Situ Hybridization.
Jessica A Baker, Anthony N Sireci, Narasimha Marella, Holly Kay Cannon, Tyler J Marquart, Timothy R Holzer, Leslie O'Neill Reising, Joel D Cook, Sameera R Wijayawardana, Juraj Bodo,[...]. Arch Pathol Lab Med 2022
1

Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies.
María San Román-Gil, Javier Pozas, Diana Rosero-Rodríguez, Jesús Chamorro-Pérez, Álvaro Ruiz-Granados, Ignacio Ruz Caracuel, Enrique Grande, Javier Molina-Cerrillo, Teresa Alonso-Gordoa. Cancer Treat Rev 2022
1

ANKRD26-RET - A novel gene fusion involving RET in papillary thyroid carcinoma.
Julia Isabelle Staubitz, Thomas Johannes Musholt, Arno Schad, Erik Springer, Hauke Lang, Krishnaraj Rajalingam, Wilfried Roth, Nils Hartmann. Cancer Genet 2019
7

RET Receptor Tyrosine Kinase: Role in Neurodegeneration, Obesity, and Cancer.
Arun Kumar Mahato, Yulia A Sidorova. Int J Mol Sci 2020
9

Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer.
Renuka Raman, Jacques A Villefranc, Timothy M Ullmann, Jessica Thiesmeyer, Viviana Anelli, Jun Yao, James R Hurley, Chantal Pauli, Rohan Bareja, Kenneth Wha Eng,[...]. J Exp Med 2022
0

Novel rearrangements involving the RET gene in papillary thyroid carcinoma.
Julia Isabelle Staubitz, Arno Schad, Erik Springer, Krishnaraj Rajalingam, Hauke Lang, Wilfried Roth, Nils Hartmann, Thomas Johannes Musholt. Cancer Genet 2019
15